-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - malignancies and/
or head and neck cancer (an off-
label use). … indicative of
its use in malignant neoplasms
of the genitourinary tract (e.g.,
bladder cancer). … both malignant neoplasm of pancreas
(157) and esophagus (150), appeared in
23 percent of beneficiaries … Sixty-seven
percent of beneficiaries with an imatinib
order had a prior diagnosis of malignant
neoplasm … Denileukin was accompanied by a prior diagnosis of malignant neoplasm
of lymphatic and hematopoietic
-
effectivehealthcare.ahrq.gov/products/pediatric-cancer-survivorship/protocol
June 24, 2020 - kidney failure, liver disease, osteopenia and osteoporosis, neurocognitive deficits, and secondary malignancies … for CCS is critical to minimize and alleviate disparities due to the adverse sequelae of their prior malignancy … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan … *” OR “oncolog*” OR “neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR “malignan
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-protocol.pdf
June 05, 2024 - suggest these are biologically different
tumors.26 Earlier diagnosis of tumors with certain molecular … OR "tumor DNA methylation"[tiab] OR
"tumor DNA methylation"[tiab]
345,654
#2 "Adrenal Gland Neoplasms … "[tiab] OR "multi-site cancers"[tiab] OR "multisite
neoplasm"[tiab:~3] OR "multi-site neoplasm"[tiab … OR "tumor DNA
methylation"[tiab] OR "tumor DNA methylation"[tiab]
345,654
#2 "Adrenal Gland Neoplasms … cancer"[tiab] OR "multi-site cancers"[tiab]
OR "multisite neoplasm"[tiab:~3] OR "multi-site neoplasm
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
February 04, 2014 - Cancer Network.2 The
consensus definition of head and neck cancer includes tumors of:
• larynx; … cancer;
• esophageal cancer; and
• trachea tumors. … [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR
tumour [TIAB] OR tumours [TIAB] OR cancer [TIAB] OR cancers … "[Mesh]
OR
(("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR
tumour [TIAB … "[Mesh]
OR
(("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR
tumour [
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
April 20, 2015 - early-stage cancers, the death rate from kidney cancer has
not changed significantly over the same … in the range of 0.55 to 0.65.[3, 16-
18] The best predictors of malignancy are male sex and tumor size … – who have the highest risk of having aggressive malignancies. … Given the increased incidence in early, low-stage tumors without improvement in cancer-related
deaths … Frank, I., et al., Independent validation of the 2002 American Joint Committee on cancer
primary tumor
-
effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
February 01, 2016 - Given the increased
incidence in early, low-stage tumors without improvement
in cancer-related deaths … Tumor
Characteristics
9 Low
Increasing RENAL nephrometry score is consistently associated with malignancy … Importantly, cancer-specific survival was associated with
tumor size/stage, but not partial or radical … However, differences in cancer-specific
survival among modalities is likely unrelated to age or tumor … Current
composite models do not reliably predict malignancy;
however, tumor size and male sex are most
-
effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization/research
August 26, 2011 - Points #7: Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer … malignancies and/or head and neck cancer (an off-label use). … indicative of its use in malignant neoplasms of the genitourinary tract (e.g., bladder cancer). … to the National Comprehensive Cancer Network. … Such use is not uncommon in cancer patients who have failed more traditional treatments.
-
effectivehealthcare.ahrq.gov/products/head-neck-cancer-update/research-protocol
February 04, 2014 - tumors
otologic tumors
cutaneous tumors of the head and neck (including melanoma)
thyroid cancer … parathyroid cancer
esophageal cancer
trachea tumors
All therapeutic strategies will be included … OR
(("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB] OR tumours … "[Mesh]
OR
(("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB … "[Mesh]
OR
(("Neoplasms"[Mesh] OR neoplasms [TIAB] OR tumor [TIAB] OR tumors [TIAB] OR tumour [TIAB
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
August 10, 2016 - ) and squamous cell carcinoma (SCC),
are the most common malignancies in the U.S.1 BCC and SCC are collectively … Cancer Council Australia and
Australian Cancer Network. 2008.
26. … or "Oropharyngeal Neoplasms"[Mesh] OR Pharynx OR
Pharyngeal neoplasms OR "Pharyngeal Neoplasms"[Mesh … ] or "Lung Neoplasms"[Mesh]
or "Urinary Bladder Neoplasms"[Mesh] or "Uterine Cervical Neoplasms"[Mesh … ] or
"Esophageal Neoplasms"[Mesh] or "Laryngeal Neoplasms"[Mesh]))
AND
(((Surger* or surgic*) and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
August 09, 2013 - Studies that report data by tumor (e.g., percentage of pancreatic adenocarcinoma tumors that
were correctly … Diagnostic management of pancreatic cancer. Cancers.
2011 Mar;3(1):494-509.
5. … exp pancreas, exocrine/) and (neoplasm/ or adenocarcinoma/ or
neoplasms/)) or pancreas tumor/ or Pancreatic … r$ or sarcoma$ or neoplasm$ or
carcinoma$ or adenocarcinoma$)).mp.
4 neuroendocrine tumors/ and … and imaging and
diagnosis
17 and 23
25 Staging Cancer staging/ or Neoplasm staging/
26 ((mass
-
effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research-protocol
June 16, 2010 - The prevalence of anemia varies according to the type of neoplasia. 7 Patients with hematological malignancies … versus hematological malignancies versus mixed (studies including both solid tumors and hematological … * OR tumor OR tumors OR tumour* OR neoplas* OR carcinom*
#59
Search erythropoietin OR epoetin* OR … AND
("Neoplasms"[Mesh] OR "Carcinoma"[Mesh] OR malignan* OR cancer OR cancers OR cancerous OR oncolog … * OR myelodysplas* OR tumor OR tumors OR tumour* OR neoplas* OR carcinom*)
AND
("adverse effects
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
May 01, 2012 - analysis included all Medicare ben-
eficiaries with claims indicating a diagno-
sis in the malignant or benign … neoplasms
range of the ICD-9 codes (140-239) and
receipt of proton beam therapy (HCPCS
77520-77525 … cancers (Table 7). … Typically a prostate cancer case will have this daily
charge 30 times, and ocular tumor 5 times. … fur-
ther multiplied by the fact that with 6 to 8 weeks of therapy (compared
to one week for ocular neoplasms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
June 01, 2020 - kidney failure, liver disease, osteopenia and osteoporosis, neurocognitive deficits, and
secondary malignancies … for CCS is critical to minimize and alleviate disparities due to
the adverse sequelae of their prior malignancy … *” OR “oncolog*” OR
“neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR
“malignan … *” OR “oncolog*” OR
“neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR
“malignan … *” OR “oncolog*” OR
“neoplasm” OR “neoplasms” OR “tumor” OR “tumors” OR “cancer” OR “cancers” OR
“malignan
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/protocol
September 12, 2019 - non-dermatologic malignancy (174,650 new cases) and the second leading cause of cancer death (31,620 … With AS, tumors are not immediately removed, irradiated, or ablated. 3 , 4 Instead, tumors are monitored … Stage 1
T2= tumor Stage 2
T3= tumor Stage 3
T4= tumor Stage 4
WMD= weighted mean differences … / (121506)
2 (prostat* and (neoplasm* or cancer* or carcinoma*)).ti,ab. (142514)
3 watchful … / (9241)
2 (prostat$.ti,ab. or Prostate/) and (cancer.ti,ab. or Neoplasms/ or neoplasm$.mp. or
-
effectivehealthcare.ahrq.gov/products/renal-cancer/clinician
July 18, 2017 - Renal cell carcinoma accounts for more than 94 percent of kidney malignancies. … treatment for patients with clinical stage T1a tumors (≤4 cm in diameter) and T1b tumors (4–7 cm) and … Tumor size and male sex are the factors that are statistically significantly associated with malignancy … Tumor Size
12 (9,401)
A positive relationship between tumor size and malignancy risk was found. … score b and malignancy risk was found.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-test_research-protocol.pdf
October 14, 2011 - (particularly cancerous tumors with aggressive features)? … Indolent Cancers of the Prostate (Key Question 3)
Figure 2. … ] (OR text words “prostate cancer”, “prostatic
cancer”, “prostate neoplasms”, “prostatic neoplasms” … Characteristics
Age
Race
Benign prostatic hyperplasia
High-grade prostatic intraepithelial neoplasia … "[Mesh] OR "prostatic neoplasms" OR "prostate neoplasms" OR
"prostatic cancer" OR "prostate cancer"
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
September 01, 2014 - Studies that reported data by tumor (e.g., x percent
of pancreatic adenocarcinoma tumors were correctly … imaging
and pathology that showed a benign lesion, e.g., branch
duct intraductal papillary mucinous neoplasia … Diagnostic management of
pancreatic cancer. Cancers. 2011 Mar;3(1):494-509.
5. … Pancreatic,
neuroendocrine GI, and adrenal cancers. … compared with
Fluorodeoxyglucose positron emission tomography/computed
tomography for pancreatic malignancy
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research-protocol
October 14, 2011 - (particularly cancerous tumors with aggressive features)? … Indolent Cancers of the Prostate (Key Question 3)
Figure 2. Analytic framework for KQ 3. … OR text words “prostate cancer”, “prostatic cancer”, “prostate neoplasms”, “prostatic neoplasms”) AND … Characteristics
Age
Race
Benign prostatic hyperplasia
High-grade prostatic intraepithelial neoplasia … "[Mesh] OR "prostatic neoplasms" OR "prostate neoplasms" OR "prostatic cancer" OR "prostate cancer"
-
effectivehealthcare.ahrq.gov/products/cancer-pancreas/research-protocol
August 09, 2013 - Diagnostic management of pancreatic cancer. Cancers. 2011 Mar;3(1):494-509. … Pancreatic, neuroendocrine GI, and adrenal cancers. … / or exp pancreas, exocrine/) and (neoplasm/ or adenocarcinoma/ or
neoplasms/)) or pancreas tumor … r$ or sarcoma$ or neoplasm$ or
carcinoma$ or adenocarcinoma$)).mp.
4
neuroendocrine tumors … and imaging and diagnosis
17 and 23
25
Staging
Cancer staging/ or Neoplasm staging/
26
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
June 16, 2008 - Clinical study of proton radiotherapy in urological cancers
[Japanese]. … Proton therapy for head and neck malignancies at
Tsukuba. … Cancer Journal 2006 Apr;12(2):155-9.
16630407 No malignancy
Makarova GV, Matveev BP, Leonova NS, … [Use of high energy protons
in the combination treatment of cervix neoplasms] [Russian]. … Uveal lymphoid neoplasia: a clinical-pathologic
correlation and review of the early form.